🚨 Once hailed as a beacon of hope against COVID-19, Remdesivir's past and present tell a more troubling story.

In this episode of Effects on the Side, we delve into:

The drug's alarming 53% mortality rate in Ebola trials.

Its rapid endorsement during the pandemic despite questionable efficacy.

Investigations into financial ties influencing its promotion.

The ethical implications of prioritizing profit over patient safety.

🔎 Join us as we uncover the complex web behind Remdesivir and what it means for future medical interventions.

🎙️ Listen now on Effects on the Side.